Clinical Trial Update: Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating intranasal dexmedetomidine plus ketamine for procedural sedation in patients with fractures or dislocations; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dislocation
• Fracture

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Ketamine (ketamine)

Snippet

Sponsor: Naveen Poonai | Conditions: Fracture, Dislocation | Phase 2, Phase 3 | Status: RECRUITING